Hope Mueller

Hope Mueller joined Currax Pharmaceuticals in 2022 as the Senior Vice President of Corporate Development & Strategy. With over 20 years of experience in the pharmaceutical industry, Hope has built a distinguished career across quality, operations, regulatory, corporate governance and business development. Her leadership spans both contract manufacturing organizations and global biopharma companies, where she has consistently been called upon to turn around underperforming divisions, build functions from the ground up and lead high-impact cross-functional programs.

Hope started her career in the microbiology laboratory and rose through the ranks at organizations such as Eli Lilly, Baxter Healthcare and Catalent Pharma Solutions. She joined Crealta Pharmaceuticals as Vice President of Quality, where she built and implemented an operational framework that provided oversight for third-party organizations and guided M&A evaluation processes.

Hope went on to serve in multiple executive leadership roles at Horizon Pharma, including Vice President of Quality Operations and Integration, Continuous Improvement and R&D Program and Project Management. Her work at Horizon broadened her expertise in program execution, operational excellence and leadership of cross-functional strategic initiatives.

Hope holds a Bachelor of Science in Biology from Indiana University Bloomington and an MBA from the Kellogg School of Management at Northwestern University.